Literature DB >> 21757438

Statin prescriptions in UK now total a million each week.

Daniel Trusler.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21757438     DOI: 10.1136/bmj.d4350

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

1.  Rosuvastatin and atorvastatin: comparative effects on glucose metabolism in non-diabetic patients with dyslipidaemia.

Authors:  Ahmed Abbas; John Milles; Sudarshan Ramachandran
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2012-02-20

2.  Initiation rates of statin therapy for the primary prevention of cardiovascular disease: an assessment of differences between countries of the UK and between regions within England.

Authors:  Aidan G O'Keeffe; Irene Petersen; Irwin Nazareth
Journal:  BMJ Open       Date:  2015-03-06       Impact factor: 2.692

3.  Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database.

Authors:  Yana Vinogradova; Carol Coupland; Peter Brindle; Julia Hippisley-Cox
Journal:  BMJ       Date:  2016-06-28

4.  The role of acid-base imbalance in statin-induced myotoxicity.

Authors:  Dhiaa A Taha; Cornelia H De Moor; David A Barrett; Jong Bong Lee; Raj D Gandhi; Chee Wei Hoo; Pavel Gershkovich
Journal:  Transl Res       Date:  2016-03-29       Impact factor: 7.012

5.  Time trends in the prescription of statins for the primary prevention of cardiovascular disease in the United Kingdom: a cohort study using The Health Improvement Network primary care data.

Authors:  Aidan G O'Keeffe; Irwin Nazareth; Irene Petersen
Journal:  Clin Epidemiol       Date:  2016-05-27       Impact factor: 4.790

6.  Statin use in cancer survivors versus the general population: cohort study using primary care data from the UK clinical practice research datalink.

Authors:  Kendal Chidwick; Helen Strongman; Anthony Matthews; Susannah Stanway; Alexander R Lyon; Liam Smeeth; Krishnan Bhaskaran
Journal:  BMC Cancer       Date:  2018-10-22       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.